FBXO25 Activators
The activation of FBXO25, a crucial component in the ubiquitin-proteasome system, is intricately linked to its role within the SCF (Skp1-Cul1-F-box) complex, which is essential for targeting specific proteins for ubiquitination and subsequent degradation. This process is fundamental for controlling protein levels and ensuring timely cellular responses to physiological and environmental changes. The core mechanism of FBXO25 activation revolves around its ability to recognize and bind to specific substrates, a capability that is governed by both the structural integrity of FBXO25 and the presence of post-translational modifications on its targets. Activation, in the context of FBXO25, is primarily concerned with the functional readiness of the protein to engage in ubiquitination processes, rather than being a simple binary state.
At the molecular level, the activation of FBXO25 involves several key steps that ensure its effective participation in the SCF complex. Initially, the assembly of the SCF complex, which includes FBXO25, is a prerequisite for its activation. This assembly is a highly regulated process that not only involves the physical association of FBXO25 with Skp1, Cul1, and Rbx1 but also requires the correct folding and post-translational modifications of FBXO25 itself. These modifications can include phosphorylation, which often serves as a signal for the protein to undergo conformational changes or to interact with other proteins within the complex. Once properly assembled and modified, FBXO25 is considered activated and capable of fulfilling its role in targeting specific substrates for ubiquitination.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, thereby increasing cyclic AMP (cAMP) levels in cells. Elevated cAMP activates PKA (protein kinase A), which can phosphorylate target proteins. Given the role of FBXO25 in protein ubiquitination, PKA-mediated phosphorylation could enhance FBXO25's recognition of substrates or its activity within the SCF (SKP1-CUL1-F-box protein) complex. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane is an activator of Nrf2, which moves to the nucleus and binds to antioxidant response elements (ARE) in the promoter regions of target genes. Activation of Nrf2 can lead to the expression of genes involved in the antioxidant defense system, which may indirectly enhance FBXO25's activity by maintaining cellular redox homeostasis, thus preserving the protein's structure and function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), leading to the stabilization of proteins and the modulation of Wnt signaling. Inhibition of GSK-3 could enhance FBXO25's activity by increasing the stability of its protein substrates within the Wnt pathway or by altering the signaling context in which FBXO25 operates. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression by activating nuclear receptors. It could enhance FBXO25's activity by influencing gene expression patterns and cellular differentiation states, potentially increasing the demand for protein ubiquitination and degradation processes in which FBXO25 is involved. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that alters chromatin structure and affects gene expression. It may indirectly enhance FBXO25 activity by upregulating the expression of genes encoding proteins that are substrates for FBXO25, thereby increasing its ubiquitination activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, a protein deacetylase that impacts various cellular processes including DNA repair and apoptosis. By activating SIRT1, resveratrol could indirectly enhance FBXO25 activity by modulating the acetylation status of proteins and affecting their stability or ubiquitination. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which is a sensor of cellular energy status. Activation of AMPK may indirectly enhance FBXO25 activity by altering cellular energy balance and potentially modifying the ubiquitination process to regulate energy-related proteins. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to modulate multiple signaling pathways, including inhibition of NF-kB. By suppressing NF-kB signaling, curcumin could indirectly enhance FBXO25 activity by reducing the expression of anti-apoptotic proteins, which may be substrates for FBXO25-mediated ubiquitination. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the MAPK/ERK pathway. Inhibition of MEK could indirectly enhance FBXO25 activity by altering the phosphorylation state of proteins, potentially making them more susceptible to FBXO25-mediated ubiquitination. | ||||||